The report examines how advances in genomics, AI, and precision therapeutics are transforming rare disease care and creating new opportunities for scientific discovery and therapeutic innovation. It explores how Abu Dhabi can connect its population-scale genomics, clinical, research, and innovation capabilities to build a Genomics Oasis – a connected ecosystem that translates genomic insights into earlier diagnosis, more precise interventions and new discoveries, while generating lasting health, scientific, and economic value.